Anti-TAF1B monoclonal antibody

Pre-made anti-TAF1B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TAF1B/TAF1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1878-Ab-1/ GM-Tg-hg-IP1878-Ab-2Anti-Human TAF1B monoclonal antibodyHuman
GM-Tg-rg-IP1878-Ab-1/ GM-Tg-rg-IP1878-Ab-2Anti-Rat TAF1B monoclonal antibodyRat
GM-Tg-mg-IP1878-Ab-1/ GM-Tg-mg-IP1878-Ab-2Anti-Mouse TAF1B monoclonal antibodyMouse
GM-Tg-cynog-IP1878-Ab-1/ GM-Tg-cynog-IP1878-Ab-2Anti-Cynomolgus/ Rhesus macaque TAF1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1878-Ab-1/ GM-Tg-felg-IP1878-Ab-2Anti-Feline TAF1B monoclonal antibodyFeline
GM-Tg-cang-IP1878-Ab-1/ GM-Tg-cang-IP1878-Ab-2Anti-Canine TAF1B monoclonal antibodyCanine
GM-Tg-bovg-IP1878-Ab-1/ GM-Tg-bovg-IP1878-Ab-2Anti-Bovine TAF1B monoclonal antibodyBovine
GM-Tg-equg-IP1878-Ab-1/ GM-Tg-equg-IP1878-Ab-2Anti-Equine TAF1B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1878-Ab-1/ GM-Tg-hg-IP1878-Ab-2; GM-Tg-rg-IP1878-Ab-1/ GM-Tg-rg-IP1878-Ab-2;
GM-Tg-mg-IP1878-Ab-1/ GM-Tg-mg-IP1878-Ab-2; GM-Tg-cynog-IP1878-Ab-1/ GM-Tg-cynog-IP1878-Ab-2;
GM-Tg-felg-IP1878-Ab-1/ GM-Tg-felg-IP1878-Ab-2; GM-Tg-cang-IP1878-Ab-1/ GM-Tg-cang-IP1878-Ab-2;
GM-Tg-bovg-IP1878-Ab-1/ GM-Tg-bovg-IP1878-Ab-2; GM-Tg-equg-IP1878-Ab-1/ GM-Tg-equg-IP1878-Ab-2
Products NameAnti-TAF1B monoclonal antibody
Formatmab
Target NameTAF1B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TAF1B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1878-Ag-1Recombinant multi-species TAF1B/ MGC:9349/ RAF1B protein


    Target information

    Target IDGM-IP1878
    Target NameTAF1B
    Gene ID9014,21340,690450,701733,100684854,101095736,511236,100072474
    Gene Symbol and Synonyms4930408G01Rik,A230108M10Rik,MGC:9349,p63,RAF1B,RAFI63,SL1,TAF1B,TAFI63,TAFI68,Tafi86
    Uniprot AccessionQ53T94,D3ZYB7,Q1JQD6
    Uniprot Entry NameTAF1B_HUMAN,TAF1B_RAT,TAF1B_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000115750
    Target ClassificationN/A

    The target: TAF1B, gene name: TAF1B, also named as MGC:9349, RAF1B, RAFI63, SL1, TAFI63. Initiation of transcription by RNA polymerase I requires the formation of a complex composed of the TATA-binding protein (TBP) and three TBP-associated factors (TAFs) specific for RNA polymerase I. This complex, known as SL1, binds to the core promoter of ribosomal RNA genes to position the polymerase properly and acts as a channel for regulatory signals. This gene encodes one of the SL1-specific TAFs. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.